𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prognostic implications of loss of heterozygosity at 8p21 and 9p21 in head and neck squamous cell carcinoma

✍ Scribed by Steven W. Coon; Adnan T. Savera; Richard J. Zarbo; Michael S. Benninger; Gary A. Chase; Benjamin A. Rybicki; Daniel L. Van Dyke


Publisher
John Wiley and Sons
Year
2004
Tongue
French
Weight
118 KB
Volume
111
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Loss of heterozygosity (LOH) in chromosomal regions that harbor tumor suppressor genes from tumor tissue may lead to decreased survival time in cancer patients with squamous cell carcinoma of the head and neck (HNSCC). We studied 8 regions frequently lost in HNSCC in 150 patients having a primary diagnosis of HNSCC. Tumor and normal tissue DNA were genotyped for microsatellite repeat markers in 8 unlinked chromosomal regions. The association between LOH and death from HNSCC was investigated, weighted by number of informative markers per region and adjusted for age at diagnosis, self‐reported race, tumor stage and current smoking status. LOH at 3 chromosomal regions were independently associated with reduced survival. A greater risk for cancer mortality was observed for LOH at chromosomal regions 3p24.3‐p14.3 (p = 0.02), 8p21.3‐p11.21 (p = 0.02) and 9p24.2‐p21.2 (p = 0.03). In these regions, LOH at one or more markers was observed in 66.9%, 43.3% and 60.6% of patients, respectively. Survival times were significantly shorter for those with LOH at marker NEFL on 8p21.2 (relative risk = 6.15; p = 0.0002) and at D9S126 on 9p21.2 (relative risk = 5.96; p = 0.0003). Our results indicate that LOH at several chromosomal sites may offer additional independent prognostic information beyond traditional indicators such as tumor stage and age. Β© 2004 Wiley‐Liss, Inc.


πŸ“œ SIMILAR VOLUMES


Loss of heterozygosity at 9p and p53 imm
✍ A. Peggy Graveland; Pawel J. Golusinski; Marijke Buijze; Rinze Douma; Nanet Sons πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 317 KB

## Abstract A major problem in head and neck cancer surgery is the high rate of local relapse (LR). In at least 25% of the surgically treated head and neck squamous cell carcinoma (HNSCC) patients, a genetically defined preneoplastic lesion, also known as β€œfield,” can be detected in the surgical ma

Loss of imprinting and loss of heterozyg
✍ ClΓ‘udia A. Rainho; Luiz P. Kowalski; Silvia R. Rogatto πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 180 KB

## Abstract ## Background __IGF2__ and __H19__ are reciprocal imprinted genes with paternal and maternal monoallelic expression, respectively. This is interesting, because __IGF2__ is known as a growth factor, and __H19__ encodes a RNA with putative tumor suppressor action. Furthermore, __IGF2__ a

Loss of heterozygosity at chromosome seg
✍ Chan Choi; Mi Hwa Kim; Sang-Woo Juhng; Bong-Ryoul Oh πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 107 KB πŸ‘ 1 views

To identify the putative tumor-suppressor gene (TSG) involved in transitional-cell carcinoma (TCC) of the urinary bladder, we undertook an allelotyping analysis in 48 cases of TCC. Relatively high percentages of allelic loss were found in 2p (5 of 23, 21.7%), 8p (9 of 21, 42.9%), 9p (4 of 20, 20.0%)

Prognostic significance of p16INK4a alte
✍ Viviana Bazan; Ines Zanna; Manuela Migliavacca; Maria Teresa Sanz-Casla; Maria L πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 144 KB πŸ‘ 1 views

## Abstract The __p16__^INK4a^ gene, localized within chromosome 9p21, has been identified as a cyclin‐dependent kinase inhibitor and may negatively regulate the cell cycle acting as a tumor suppressor. Genetic alterations involving the 9p21 region are common in human cancers. A consecutive series

Co-overexpression of p21 and Ki-67 in he
✍ Claude A. Fischer; Minoa Jung; Inti Zlobec; Edith Green; Claudio Storck; Luigi T πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 334 KB πŸ‘ 1 views

Background. Head and neck squamous cell carcinomas (HNSCC) are treated by surgery or radiotherapy. Tumor cell death-related markers, such as p21 and Ki-67, may predict response to therapy and improve treatment choice. We evaluated and compared the effect of their coexpression between patients treate

Loss of heterozygosity at chromosomes 8p
✍ Schullerus, Dietlinde; Herbers, Jutta; Chudek, Jerzy; Kanamaru, Hiroshi; Kovacs, πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 92 KB πŸ‘ 2 views

In this study, 105 non-papillary renal cell carcinomas (RCCs) have been examined for allelic loss at the chromosome 8p12-21.1, 9p21, and 14q24.2-qter regions, each by two highly polymorphic microsatellites. Loss of heterozygosity (LOH) was detected at both chromosome 8p and 9p in 33 per cent of the